All News

Found 794,171 articles

• GSW Worldwide To Lead Saforis(TM) Launch Campaign For MGI Pharma Inc.

  11/17/2005

• SBIR Awarded Phase I Galenea To Develop siRNA Products For Prevention And Treatment Of Influenza Infection

  11/17/2005

• Labopharm's Once-Daily Tramadol Product Launched In Germany

  11/17/2005

• Abbott Laboratories Release: New Data Show A Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated Continued Efficacy And Favorable Resistance Profile For Patients Through Seven Years Of Initial HIV Therapy

  11/17/2005

• Pfizer Inc. Release: Published Study Shows Benefits Of Revatio (Sildenafil Citrate) In Patients With Pulmonary Arterial Hypertension

  11/17/2005

• Labopharm's Once-Daily Tramadol Product Launched In Germany

  11/17/2005

• Nanogen, Inc. Issued Patent For Technology Enabling Assay Development To Detect Difficult Nucleic Acid Sequences

  11/17/2005

• Digene Corporation Announces Pricing Of Public Offering Of Common Stock

  11/17/2005

• IMS Health Authorizes New Stock Repurchase Program To Buy Up To 10 Million Shares

  11/17/2005

• Emdeon Corporation Announces Its Intention To Commence A Tender Offer To Repurchase Up To 60,000,000 Shares Of Its Common Stock

  11/17/2005

• Sangamo BioSciences, Inc. Reports On Registered Direct Offering

  11/17/2005

• Myogen Files Shelf Registration Statement

  11/17/2005

• Protox Therapeutics Inc. Completes Oversubscribed $5.8 Million Equity Financing

  11/17/2005

• Glucose Monitoring Company Luminous Medical Lights Up With $9 Million Series A

  11/17/2005

• Boston Scientific Corporation Announces Completion Of $750 Million Senior Notes Offering

  11/17/2005

• Ciphergen Biosystems, Inc. Announces Second Quarter 2005 Restatement Decision; Receipt Of Delisting Notification From Nasdaq

  11/17/2005

• Avicena Group, Inc. Registration Statement Declared Effective By The SEC

  11/17/2005

• Genesis Bioventures Announces CLIA Certification For Its Breast Cancer Diagnostic Company, Biomedical Diagnostics

  11/17/2005

• Human Pheromone Sciences And Rubinson End Talks

  11/17/2005

• Third Point LLC To Run Slate Of 8 Nominees For Election To The Board Of Directors Of Ligand Pharmaceuticals Inc.

  11/17/2005